Paloma Partners Management CO Axogen, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $105,947 - $151,570	-15,157 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $110,039 - $162,179	15,157 New	15,157 $120,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $185,276 - $289,353	-16,111 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $171,098 - $211,376	16,111 New	16,111 $187,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $185,440 - $305,900	-7,600 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $140,600 - $217,360	7,600	7,600 $215,000

129

35.8M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $583M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.